Brian Pan
BioHealthWays, Inc.
Affiliations
State University of New York
Technologies
Medical Device
Indication
Ophthalmology
Executive Summary
View/DownloadWebsite
www.biohealthway.comBioHealthWays prevents vision loss by delivering biologics in the eye. Our implant drastically reduces injections and improves compliance & convenience. The target market is $7B+, with 12M Americans having retinal neovascular conditions.
